EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Probing Red Blood Cell Deformability in Sickle Cell Disease, Sickle Cell Trait, and Healthy Controls by Ektacytometry

Xunde Wang, Nancy Asomaning, Haiou Li, Maureen Lundt, Swee Lay Thein

eJHaem · 2026-10 · 7 (5)

DOI: 10.1002/jha2.70416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eJHaem, online erschienen am 09.10.2026. Verfasst von Xunde Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sickle Cell Branch National Heart, Lung, and Blood Institute National Institutes of Health (NIH) Bethesda Maryland USA. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Heart, Lung, and Blood Institute, U.S. Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Red blood cell (RBC) deformability is a key determinant of sickle cell disease (SCD) pathophysiology. We evaluated RBC deformability across HbSS, HbAS, and HbAA genotypes and investigated its associations with hemolysis, fetal hemoglobin (HbF), coinherited α‐thalassemia, hydroxyurea treatment, and the PIEZO1 E756del variant.

Methods

We used Lorrca ektacytometry to compare RBC deformability across 174 participants with HbSS, HbAS, and HbAA genotypes. Deformability was evaluated across a range of shear stresses, osmotic pressures, and oxygen tensions. Associations between deformability and hemolysis markers, HbF levels, α‐thalassemia status, hydroxyurea use, and the PIEZO1 E756del variant were assessed.

Results

HbSS RBCs showed markedly reduced deformability across all shear stresses, osmotic pressures, and oxygen tensions compared to HbAS and HbAA RBCs. Reduced deformability correlated with elevated markers of hemolysis, including lactate dehydrogenase (LDH) and bilirubin. Higher HbF levels were independently associated with improved RBC deformability, whereas coinherited α‐thalassemia was not associated with improved deformability. Hydroxyurea use was associated with significantly improved deformability. The PIEZO1 E756del variant was associated with reduced deformability among participants with HbSS.

Conclusion

RBC deformability is substantially impaired in HbSS and is associated with markers of hemolysis and several genetic and treatment‐related factors. These findings support Lorrca ektacytometry as a robust biomarker platform for assessing RBC health and treatment response in SCD. Trial Registration ClinicalTrials.gov identifier: NCT03685721

Schlagwörter

Stichwörter der Autor:innen

ektacytometryfetal hemoglobinhemolysis markerssickle cell disease

Autor:innen und Institutionen

  • Sickle Cell Branch National Heart, Lung, and Blood Institute National Institutes of Health (NIH) Bethesda Maryland USA.

Förderung

  • National Heart, Lung, and Blood Institute
  • U.S. Department of Health and Human Services

Zitieren

APA

Wang, X., Asomaning, N., Li, H., Lundt, M., & Thein, S. L. (2026). Probing Red Blood Cell Deformability in Sickle Cell Disease, Sickle Cell Trait, and Healthy Controls by Ektacytometry. eJHaem, 7(5). https://doi.org/10.1002/jha2.70416

Vancouver

Wang X, Asomaning N, Li H, Lundt M, Thein SL. Probing Red Blood Cell Deformability in Sickle Cell Disease, Sickle Cell Trait, and Healthy Controls by Ektacytometry. eJHaem. 2026;7(5). doi:10.1002/jha2.70416

BibTeX
@article{Wang2026,
  author = {Wang, Xunde and Asomaning, Nancy and Li, Haiou and Lundt, Maureen and Thein, Swee Lay},
  title = {Probing Red Blood Cell Deformability in Sickle Cell Disease, Sickle Cell Trait, and Healthy Controls by Ektacytometry},
  journal = {eJHaem},
  year = {2026},
  volume = {7},
  number = {5},
  doi = {10.1002/jha2.70416}
}
Kostenlos starten →